ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
11/06/2025
Voltar para busca
Dado oficial do USPTO
LINQURE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
38
Atualização mais recente
12/06/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42, 44
Data de depósito
26/05/2021
Data de registro
07/05/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/05/2024
Última transação
12/06/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
26
Localização do titular
AMSTERDAM, NL
Examinador
CHADAB, SETH
Unidade examinadora
L40
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
UNIQURE BIOPHARMA B.V.
uniQure IP B.V.
Representantes
Julianne Abelman ABELMAN LAW PLLC
Classificação técnica
Classes Nice
Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Medicinal preparations for the diagnosistreatment or prevention of Central Nervous System diseasesLiver diseasesNeuromuscular diseases and Cardiovascular diseasesviral systemsgene therapy systemsnucleic acid delivery systemsviral vectorsnon-viral vectorsgene therapy vectorsnucleic acid delivery vectorscells transformed by viral vectorsnon-viral vectorsgene therapy vectors or nucleic acid delivery vectors; Viral systemsgene therapy systemsnucleic acid delivery systems for medical purposesmedicines for the diagnosistreatment or prevention of Central Nervous System diseasesLiver diseasesNeuromuscular diseases and Cardiovascular diseases; clinical medical reagents for use in nucleic acid based therapygene therapycell therapygene diagnosis and gene testing
Classe 42
Researchproduct development and consultancy in the field of biotechnologybiologicsmedical sciencechemistry and biochemistry; Research and product development in the field of pharmaceuticspharmaceutics in the field of gene therapy
Classe 44
Gene and nucleic acid deliverygene and nucleic acid transfergene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disordersocular disordersdiseases of the nervous systemblood disordersliver disordersmuscular disordersmuscular skeletal disorderscancersinfectious diseasesinflammatory and auto-immune diseasesvascular disordersinherited disordersgenetic disorders and single gene disorders; Consultancy in the field of pharmaceuticspharmaceutics in the field of gene therapy
Publicações
Histórico de despachos e eventos da marca no USPTO.
38 publicações encontradas
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
04/06/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/06/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
04/06/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/06/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/06/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/06/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/06/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/05/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
07/05/2024
CHPB
POST PUBLICATION AMENDMENT - ENTERED
27/01/2023
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
26/01/2023
APET
ASSIGNED TO PETITION STAFF
25/01/2023
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
12/01/2023
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
18/08/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
20/07/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
20/07/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
20/07/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
20/07/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
19/07/2022
PUBO
PUBLISHED FOR OPPOSITION
19/07/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
29/06/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/06/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
31/05/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/05/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
31/05/2022
ALIE
ASSIGNED TO LIE
28/05/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
22/05/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
22/05/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
22/05/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
22/05/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
22/05/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/02/2022
GNSL
LETTER OF SUSPENSION E-MAILED
10/02/2022
CNSL
SUSPENSION LETTER WRITTEN
10/02/2022
DOCK
ASSIGNED TO EXAMINER
08/02/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
20/08/2021
NWAP
NEW APPLICATION ENTERED
29/05/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LINQURE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.